Futures Tumble, Dollar Soars After European PMIs Slump, Putting Recovery In Doubt
Macro Briefing | 21 August 2020
Renowned EU Scientist: COVID-19 Was Engineered In China Lab, Effective Vaccine "Unlikely"
AstraZeneca’s Imfinzi Wins Japan Approval For Small Cell Lung Cancer
ESG Investment Filters – We Must Clean the Lens to Maintain Forward Momentum
Mid-Market Update: US data disappoints, EU virus surges, Oil volatile, Gold slumps
Global Stocks Slide After Fed Minutes Disappoint
BofA Puts Cost Of Re-Shoring At $1 Trillion
Greece Imposes New Restrictions After Reporting Record COVID-19 Jump: Live Updates
Futures At All Time High As Target Reports Record Quarter
GBPUSD rallies to new 2020 high
Gilead Sinks After-Hours As FDA Rejects Rheumatoid Arthritis Application
Biden's long foreign-policy record signals how he'll reverse Trump, rebuild old alliances and lead the pandemic response
Titan Pharmaceuticals (TTNP) Stock Loses a Wall Street Supporter
These 2 Beaten-Down Stocks Are Poised to Bounce Back, Say Analysts
"Massively Compromised" - Corporate Debt Issuance Soars To Record Highs
AstraZeneca is changing up dosing regimens of its checkpoint player in the face of the pandemic. The FDA appears ready to make a quick assist
Futures Inch To Record High After Walmart Earnings Smash Expectations; Dollar Hits 2 Year Low
AstraZeneca Gets FDA Priority Review For New Dose Of Imfinzi Cancer Drug
Canada Shrugs Off Loss of Morneau and Gold Reclaims $2000 Threshold
AZ aims to cut cancer clinic visits with new Imfinzi regimen
Could AI avert a future coronavirus pandemic?
Weekly Market Outlook: Brexit talks, FOMC and Oil markets are in focus
Quick Note on Lost GDP Due to Shutdowns
Key Events In The Coming Week: Dem Convention, FOMC Minutes, Earnings Season Ends
Futures Rise To All Time Highs After Chinese Liquidity Injection
EU places firm order for AZ/Oxford Uni’s ChAdOx1 COVID-19 vaccine
AstraZeneca Clinches First Supply Deal With EU For Covid-19 Vaccine
Altria vs Philip Morris: Which Stock Is A More Compelling Buy?
Novavax Pops 7% On South Korea Deal For Global Covid-19 Vaccine Supply